Legence Corp. (LGN) CEO awarded new stock options and RSUs

Rhea-AI Filing Summary

Legence Corp. reported that Chief Executive Officer Jeffrey Sprau received new equity awards. He was granted employee stock options for 63,177 shares of Class A common stock at an exercise price of $50.90 per share, with 63,177 underlying shares reported following the grant. He also received 34,167 shares of Class A common stock as a grant, bringing his direct common stock holdings to 96,667 shares after the transaction. The stock options and the underlying restricted stock units vest in three substantially equal annual installments on the first, second, and third anniversaries of the award date, generally conditioned on continued employment, and the options expire on the tenth anniversary.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Sprau Jeffrey

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Options	63,177	$0.00	--
Grant/Award	Class A Common Stock	34,167	$0.00	--

Holdings After Transaction: Employee Stock Options — 63,177 shares (Direct); Class A Common Stock — 96,667 shares (Direct)

Footnotes (1)

1. The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive, at vesting, one share of Legence Corp.'s Class A common stock, par value $0.01 per share. The Restricted Stock Units vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date. The options will vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date. The options expire on the tenth anniversary of the date of the award.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sprau Jeffrey

(Last) (First) (Middle)

C/O LEGENCE CORP.

1601 LAS PLUMAS AVENUE

(Street)

SAN JOSE CALIFORNIA 95133

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Legence Corp. [ LGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock(1)	03/16/2026		A		34,167	A	$0	96,667	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options	$50.9	03/16/2026		A		63,177		(2)	(2)	Class A Common Stock	63,177	$0	63,177	D

Explanation of Responses:

1. The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive, at vesting, one share of Legence Corp.'s Class A common stock, par value $0.01 per share. The Restricted Stock Units vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date.

2. The options will vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date. The options expire on the tenth anniversary of the date of the award.

	/s/ Bryce Seki, as attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Legence Corp. (LGN) disclose for Jeffrey Sprau?

Legence Corp. disclosed that CEO Jeffrey Sprau received equity compensation grants, including stock options and Class A common shares. These awards are part of his compensation package and vest over time, aligning his interests with long-term company performance.

How many stock options did the Legence (LGN) CEO receive in this Form 4?

Jeffrey Sprau received employee stock options covering 63,177 shares of Legence Corp. Class A common stock at a $50.90 exercise price. These options vest in three substantially equal annual installments, subject generally to his continued employment through each vesting date.

What stock grants of Class A common stock were reported for Legence (LGN) CEO?

The filing shows Jeffrey Sprau was granted 34,167 shares of Legence Corp. Class A common stock. Following this grant, his direct holdings increased to 96,667 shares. The grant reflects restricted stock units that convert into shares as they vest over three years.

What is the vesting schedule for the Legence (LGN) CEO’s new equity awards?

Both the restricted stock units and the options vest in three substantially equal installments on the first, second, and third anniversaries of the award date. Vesting is generally conditioned on Jeffrey Sprau remaining employed with Legence Corp. through each applicable vesting date.

When do the Legence Corp. (LGN) CEO’s new stock options expire?

The stock options granted to CEO Jeffrey Sprau expire on the tenth anniversary of the award date. This long-dated expiration gives him a multi-year window to exercise the options once vested, subject to standard company and regulatory requirements.